This event is part of the JCB Bioethics Seminar Series 2024-25

Full Title: 43rd Philippa Harris Lecture on Bioethical Issues in Cancer Care - Cancer, Ethics and Artificial Intelligence: (Almost) Everything is Under Control

Abstract:
Rarely in history have so many people been simultaneously hyperventilating over new technology as they – we – are now over Artificial Intelligence. Though this technology will transform the way cancer is prevented, diagnosed and treated, our breathless adoption of intelligent machines should be guided appropriately … and at least a little skeptically. Indeed, there are now hundreds of AI guidance documents, and no clear way to choose among or synthesize them. The good news is that the need for sober guidance and oversight is uncontroversial. The challenge is that in the Wall Street-fueled fervor over intelligent machines, we risk losing sight of the way patients will use this technology directly, albeit without adequate education or support. We want an algorithm to supervise our use of algorithms, but our health care systems have never done a particularly good job fostering meaningful education. The opportunity for improvement has never been better.

Speaker:
Kenneth W. Goodman
Ph.D., FACMI, FACE
Founder and Director, Institute for Bioethics and Health Policy
Director, University of Miami Ethics Programs
Director, Data Ethics and Society, Institute for Data Science and Computing
Professor in Department of Medicine
Miami Miller School of Medicine

12:00 - Introduction and History of the Philippa Harris Lecture Series
12:10 - Introduction of the Speaker
12:15 - Speaker Presentation
1:00 - Question and Answer Period

The Philippa Harris lecture was established by Mr. and Mrs. Bill and Pat Harris in 1981 to celebrate the life of their daughter, Pippa, who died from cancer at the age of nineteen. The lecture is shared between the Princess Margaret Cancer Centre, the UHN Bioethics Program, and the University of Toronto Joint Centre for Bioethics.

свернуть